↓ Skip to main content

Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands

Overview of attention for article published in Cost Effectiveness and Resource Allocation, November 2007
Altmetric Badge

Citations

dimensions_citation
8 Dimensions

Readers on

mendeley
38 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Cost-effectiveness of tipranavir versus comparator protease inhibitor regimens in HIV infected patients previously exposed to antiretroviral therapy in the Netherlands
Published in
Cost Effectiveness and Resource Allocation, November 2007
DOI 10.1186/1478-7547-5-15
Pubmed ID
Authors

Gijs AA Hubben, Jasper M Bos, Christa A Veltman-Starkenburg, Simon Stegmeijer, Henrik W Finnern, Bregt S Kappelhoff, Kit N Simpson, Andrea Tramarin, Maarten J Postma

Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 38 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 1 3%
United States 1 3%
Tanzania, United Republic of 1 3%
Unknown 35 92%

Demographic breakdown

Readers by professional status Count As %
Student > Master 10 26%
Researcher 8 21%
Other 4 11%
Student > Doctoral Student 3 8%
Professor > Associate Professor 3 8%
Other 7 18%
Unknown 3 8%
Readers by discipline Count As %
Medicine and Dentistry 14 37%
Economics, Econometrics and Finance 5 13%
Nursing and Health Professions 3 8%
Social Sciences 3 8%
Biochemistry, Genetics and Molecular Biology 2 5%
Other 8 21%
Unknown 3 8%